A detailed history of First Affirmative Financial Network transactions in Novartis Ag stock. As of the latest transaction made, First Affirmative Financial Network holds 7,714 shares of NVS stock, worth $748,875. This represents 0.5% of its overall portfolio holdings.

Number of Shares
7,714
Previous 5,805 32.89%
Holding current value
$748,875
Previous $618,000 43.53%
% of portfolio
0.5%
Previous 0.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$106.13 - $120.89 $202,602 - $230,779
1,909 Added 32.89%
7,714 $887,000
Q2 2024

Jul 10, 2024

BUY
$92.57 - $107.37 $97,013 - $112,523
1,048 Added 22.03%
5,805 $618,000
Q1 2024

Apr 11, 2024

SELL
$95.27 - $108.47 $20,768 - $23,646
-218 Reduced 4.38%
4,757 $460,000
Q4 2023

Jan 08, 2024

SELL
$92.27 - $101.54 $5,628 - $6,193
-61 Reduced 1.21%
4,975 $502,000
Q3 2023

Oct 16, 2023

SELL
$94.73 - $105.13 $21,598 - $23,969
-228 Reduced 4.33%
5,036 $512,000
Q2 2023

Jul 10, 2023

SELL
$92.52 - $104.91 $21,279 - $24,129
-230 Reduced 4.19%
5,264 $531,000
Q1 2023

Apr 11, 2023

SELL
$80.03 - $92.81 $34,332 - $39,815
-429 Reduced 7.24%
5,494 $505,000
Q4 2022

Jan 23, 2023

SELL
$75.55 - $92.52 $35,961 - $44,039
-476 Reduced 7.44%
5,923 $0
Q3 2022

Oct 20, 2022

SELL
$74.61 - $87.26 $65,209 - $76,265
-874 Reduced 12.02%
6,399 $486,000
Q2 2022

Jul 13, 2022

SELL
$80.52 - $93.75 $30,356 - $35,343
-377 Reduced 4.93%
7,273 $615,000
Q1 2022

Apr 12, 2022

BUY
$80.11 - $90.62 $62,165 - $70,321
776 Added 11.29%
7,650 $671,000
Q4 2021

Feb 15, 2022

BUY
$79.7 - $88.13 $38,574 - $42,654
484 Added 7.57%
6,874 $601,000
Q3 2021

Oct 26, 2021

BUY
$81.78 - $95.14 $522,574 - $607,944
6,390 New
6,390 $523,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Affirmative Financial Network Portfolio

Follow First Affirmative Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on First Affirmative Financial Network with notifications on news.